## Abstract We present the case of a 57โyearโold male with primary squamous cell carcinoma of the thyroid (PSCCT). Epidermal growth factor receptor (EGFR) staining was strongly positive. Pharmaceuticals targeting EGFR may provide an additional therapeutic option for this rare disease with extremely
Immunohistochemical expression of EGFR and p-EGFR in oral squamous cell carcinomas
โ Scribed by Yukihiro Hiraishi; Takeshi Wada; Ken Nakatani; Kenji Negoro; Shigeyuki Fujita
- Publisher
- Springer Netherlands
- Year
- 2006
- Tongue
- English
- Weight
- 395 KB
- Volume
- 12
- Category
- Article
- ISSN
- 1219-4956
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract Overexpression of epidermal growth factor receptor (EGFR) is observed in many cancers, sometimes accompanied by gene amplification. Recently, several clinical therapies targeting EGFR were developed, but the eligibility criteria for these therapies is not fully established. To develop s
## Abstract ## __Background.__ Epidermal growth factor receptor (EGFR)โtargeted therapy has been extensively assessed in human cancer treatment. We appraised the possible role of tyrosine kinase inhibitors (TKIs) in areca quid (AQ)โassociated oral cavity squamous cell carcinomas (OSCCs) by examini
## BACKGROUND. Human chorionic gonadotropin (hCG) is a glycoprotein hormone comprised of two dissimilar subunits (โฃ and โค) and normally is synthesized by trophoblastic tissue. Although hCG expression has been identified in a variety of neoplastic tissues, to the authors' knowledge no investigation